Maternal Smoking in Pregnancy and Child's Hospital Use up to 5 Years of Age in a Data Linkage Birth Cohort.


Journal

Hospital pediatrics
ISSN: 2154-1671
Titre abrégé: Hosp Pediatr
Pays: United States
ID NLM: 101585349

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 4 12 2020
medline: 12 10 2021
entrez: 3 12 2020
Statut: ppublish

Résumé

To examine if exposure to maternal smoking during pregnancy is associated with emergency department (ED) presentation and admission through the ED in children up to 5 years after birth. Antenatal records of all children up to 5 years of age who were born in Tasmania, Australia, between July 2008 and June 2014 were linked to health service use (ED presentations and hospital admissions). Negative binomial regression was used to estimate the incidence rate ratio (IRR) and 95% confidence intervals (CIs) at ≤1 year and ≤5 years for ED presentations and admissions to the hospital through the ED for any reason and by 9 major disease categories for children exposed versus children not exposed to maternal smoking during pregnancy. Models were adjusted for sex, socioeconomic position, maternal age at birth, and region of residence. Presentations and admissions for poisoning and injuries were used as a negative control. Among 36 630 infants, 21% were exposed to maternal smoking during pregnancy. Exposed children had a 26% higher rate of presentation to the ED (IRR Higher health care service use was observed in children exposed to maternal smoking during pregnancy for a range of conditions associated with exposure to smoking. The findings reinforce the need to reduce smoking among people in their childbearing years.

Identifiants

pubmed: 33268337
pii: hpeds.2020-0150
doi: 10.1542/hpeds.2020-0150
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-16

Informations de copyright

Copyright © 2021 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Auteurs

Chigozie Ezegbe (C)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.

Amanda L Neil (AL)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.

Costan G Magnussen (CG)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.

Katherine Chappell (K)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.

Fiona Judd (F)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Perinatal and Infant Mental Health Team, Child and Adolescent Mental Health Services South, Tasmanian Health Service, Hobart, Australia; and.

Fiona Wagg (F)

New South Wales Health, Sydney, Australia.

Seana Gall (S)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia; seana.gall@utas.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH